Please assess the completion status of the following clinical trial:

Trial Title: Specialized Treatment Early in Psychosis (STEP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 16-45~2. Meets DSM-IV schizophrenia spectrum psychosis or affective psychosis according to the SCID~3. ≤8 weeks of received antipsychotic treatment lifetime at time of referral~4. Willing to be treated in New Haven~Exclusion Criteria:~1. Psychosis believed due to substance use (based on the SCID)~2. Unable or unwilling to give informed consent~3. MR as indicated by receipt of services from Dept of Mental Retardation

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Treatment as usual (Type: ACTIVE_COMPARATOR): Referral to community providers.
- STEP Care (Type: EXPERIMENTAL): Integrated and comprehensive treatment provided by a specialized team in a public mental health center.Interventions include pharmacotherapy, family education, cognitive behavioral group and individual psychotherapy and case management focused on vocational rehabilitation.

Based on this trial design, predict the completion outcome and termination type (if applicable).